| Literature DB >> 34963696 |
Richard Bauer1, Katharina Hoenes2, Tobias Meurle2, Martin Hessling2, Barbara Spellerberg3.
Abstract
Bacteria belonging to the group of ESKAPE pathogens are responsible for the majority of nosocomial infections. Due to the increase of antibiotic resistance, alternative treatment strategies are of high clinical relevance. In this context visible light as disinfection technique represents an interesting option as microbial pathogens can be inactivated without adjuvants. However cytotoxic effects of visible light on host cells have also been reported. We compared the cytotoxicity of violet and blue light irradiation on monocytic THP-1 and alveolar epithelium A549 cells with the inactivation effect on ESKAPE pathogens. THP-1 cells displayed a higher susceptibility to irradiation than A549 cells with first cytotoxic effects occurring at 300 J cm-2 (405 nm) and 400 J cm-2 (450 nm) in comparison to 300 J cm-2 and 1000 J cm-2, respectively. We could define conditions in which a significant reduction of colony forming units for all ESKAPE pathogens, except Enterococcus faecium, was achieved at 405 nm while avoiding cytotoxicity. Irradiation at 450 nm demonstrated a more variable effect which was species and medium dependent. In summary a significant reduction of viable bacteria could be achieved at subtoxic irradiation doses, supporting a potential use of visible light as an antimicrobial agent in clinical settings.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34963696 PMCID: PMC8714816 DOI: 10.1038/s41598-021-04202-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Bacterial strains used in the study and their resistance pattern.
| Species | Strain | Resistance | Source |
|---|---|---|---|
| BSU1286* | ESBL | Clinical isolate, Ulm collection | |
| ATCC43300 | MRSA | ATCC | |
| ATCC700603 | ESBL | ATCC | |
| ATCC19606 | – | ATCC | |
| ATCC27853 | – | ATCC | |
| DSM17050 | VRE | DSMZ | |
| BSU1295** | – | Clinical isolate, Ulm collection | |
| BSU1296 | – | Clinical isolate, Ulm collection | |
| BSU1297 | – | Clinical isolate, Ulm collection | |
| BSU1298 | – | Clinical isolate, Ulm collection | |
| DSM 26309 | – | DSMZ | |
| ATCC29213 | – | ATCC | |
| ATCC13565 | – | ATCC | |
| ATCC25923 | – | ATCC |
*[26]; **[55].
Figure 1Light induced cytotoxicity in the human cell lines THP-1 and A549 measured by LDH activity. (a) Irradiation of cells at a wavelength of 405 nm. (b) Irradiation of cells at a wavelength of 450 nm. The values are expressed as % cytotoxicity of the positive control (TritonX-100 treated cells). The mean and standard deviation of three independent biological replicates with each three technical replicates are illustrated. The asterisk indicates statistically significant difference between the two cell lines (*p < 0.05; **p < 0.01).
Figure 2Survival of ESKAPE pathogens in the presence of RPMI and DMEM medium irradiated with 405 nm. (a) E. coli. (b) S. aureus (ATCC43300). (c) K. pneumoniae. (d) A. baumannii. (e) P. aeruginosa (ATCC27853). (f) E. faecium. The values are expressed as log survival in comparison to starting bacterial density of 5 × 107 cfu ml−1. The mean and standard deviation of three independent biological replicates with each three technical replicates are illustrated. Statistically significant differences between the irradiated samples and their respective controls are indicated with asterisks in the respective colors (*p < 0.05; **p < 0.01).
Figure 3Survival of ESKAPE pathogens in the presence of RPMI and DMEM medium irradiated with 450 nm. (a) E. coli. (b) S. aureus (ATCC43300). (c) K. pneumoniae. (d) A. baumannii. (e) P. aeruginosa (ATCC27853). (f) E. faecium. The values are expressed as log survival in comparison to starting bacterial density of 5 × 107 cfu ml−1. The mean and standard deviation of three independent biological replicates with each three technical replicates are illustrated. Statistically significant differences between the irradiated samples and their respective controls are indicated with asterisks in the respective colors (*p < 0.05; **p < 0.01).
Figure 4THP-1 infection assay. PMA-stimulated THP-1 cells were infected at a MOI of 1. (a) P. aeruginosa (ATCC27853). (b) S. aureus (ATCC43300). Incubation of the bacteria without cells served as control. After 1 h incubation, the samples were either irradiated with 405 nm light with a dose of 25 J cm−2 or kept in the dark. Values represent survival of the irradiated samples in comparison to the dark control. The mean and standard deviation of three independent biological replicates with each three technical replicates are illustrated. Statistically significant differences between the irradiated samples and their respective controls are indicated with an asterisk (*p < 0.05).
Irradiation dose [J cm−2] per log reduction at 405 nm in comparison to the dark control.
| PBS* | RPMI | DMEM | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | |
| 525 | 625 | 725 | 100 | 100 | 150 | 100 | 150 | 150 | |
| 45 | 135 | 180 | 50 | 50 | 50 | 50 | 50 | 100 | |
| 525 | 725 | 725 | 100 | 200 | 250 | 100 | 300 | – | |
| 90 | 90 | 135 | 100 | 100 | 100 | 100 | 150 | 150 | |
| 90 | 135 | 180 | 50 | 50 | 50 | 50 | 50 | 100 | |
| 525 | 725 | – | – | – | – | – | – | – | |
*Values derived from[26].
Irradiation dose [J cm−2] per log reduction at 450 nm in comparison to the dark control.
| PBS* | RPMI | DMEM | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 1 | 2 | 3 | 1 | 2 | 3 | |
| 1750 | 2250 | 2500 | – | – | – | 1000 | – | – | |
| 160 | 240 | 320 | 1000 | 1000 | – | 1000 | – | – | |
| 1000 | 1500 | – | – | – | – | 600 | 800 | 800 | |
| 90 | 90 | 135 | 400 | 600 | 600 | 600 | 600 | 600 | |
| 90 | 135 | 180 | 400 | 600 | 600 | 400 | 600 | 600 | |
| 750 | 1000 | 1250 | 400 | – | – | 600 | 800 | – | |
*Values derived from[26].